Dr. Dany Ghassan El-Hajjar, MD

Dr. El-Hajjar practices at Baptist Primary Care Inc in Jacksonville, Florida.

Dr. El-Hajjar's NPI, 1063401057, was assigned on October 21, 2005. Dr. El-Hajjar holds Florida license ME91202.

Dr. El-Hajjar's primary practice is Baptist Primary Care Inc, at 524 Skymarks Dr, Jacksonville, FL 32218 in Duval County. The practice phone is (904) 376-3707.

Dr. El-Hajjar's primary practice is Baptist Primary Care Inc in Jacksonville, Florida. Dr. El-Hajjar is also affiliated with Baptist Medical Center Jacksonville. The medical group on file is Sound Physicians. Dmand AI also links Dr. El-Hajjar to 5 more hospitals, 13 medical groups, 6 group practices and clinics and 3 skilled nursing facilities, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. El-Hajjar practices, 15 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. El-Hajjar's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. El-Hajjar is licensed in Florida.

CMS data shows 950 Medicare services from Dr. El-Hajjar across 5 procedure codes in 2024, for 345 Medicare patients. Medicare paid $58,825 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 345 Medicare patients who saw Dr. El-Hajjar in 2024. The largest group is 75 to 84, with 137 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 19% are also on Medicaid. Their average risk score is 2.97, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. El-Hajjar's median patient age at 76, with 55% women.

In 2024, Dr. El-Hajjar wrote 346 Medicare Part D claims for 145 patients. 89% of them were for generic drugs. CMS names the drug for 139 of them, across 10 drugs with 11 or more claims each, at $2,308 in total drug cost. In 2023, CMS named 135 claims across 8 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 95 out of 100 for Dr. El-Hajjar for performance year 2024, reported through an alternative payment model (APM). Dr. El-Hajjar accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 21 general payments to Dr. El-Hajjar from 11 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Janssen Pharmaceuticals, Inc paid the most, $110.